News

22.05.2025

How Can We Use IMSS Data to Drive Systemic Change: Highlights from the IMSS Session at the EMSP Annual Conference 2025

At this year’s EMSP Annual Conference in Prague, one of the most anticipated sessions focused on the findings of the…

Invisible symptoms leave people with MS underserved and unheard, new findings show

16.05.2025

Brussels, May 16, 2025 – The European Multiple Sclerosis Platform (EMSP) has released the Impact of Multiple Sclerosis Symptoms (IMSS)…

Presenting Key Insights from the IMSS Survey at ECTRIMS 2024

23.09.2024

We are excited to share that the European Multiple Sclerosis Platform (EMSP) has presented the preliminary findings from the Impact…

12.07.2024

Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…

Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference

09.07.2024

The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…

Impact of Multiple Sclerosis Symptoms (IMSS) – Where are we now and what can you do?

24.07.2023

EMSP and 25 member organisations have launched their pan-European survey on the Impact of Multiple Sclerosis Symptoms (IMSS) in May…

10.05.2023

Impact of Multiple Sclerosis Symptoms (IMSS) Survey Now Live!

We are pleased to announce that the Impact of Multiple Sclerosis Symptoms (IMSS) survey is now officially live! Why is…

EMSP joins new EU funded project called More-EUROPA

21.12.2022

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real-world data (RWD)…

MS Nurse PRO now available in Hungarian

28.06.2022

MS Nurse PRO is pleased to announce that they are growing the nursing community. The platform is now also available…

1 2